ALNYLAM PHARMACEUTICALS, INC. Investing Cash Flow 2008-2025 | ALNY
Beta
What is investing cash flow?
Investing cash flow represents cash used for or generated from investment activities, including capital expenditures, acquisitions, and investment purchases or sales.
What is ALNYLAM PHARMACEUTICALS, INC.'s current investing cash flow?
ALNYLAM PHARMACEUTICALS, INC. (ALNY) annual investing cash flow for 2025 was $436.3M, a 473.44% increase from 2024. ALNYLAM PHARMACEUTICALS, INC. investing cash flow for the quarter ending December 31, 2025 was $-37.2M.
What was ALNYLAM PHARMACEUTICALS, INC.'s investing cash flow in 2024?
ALNYLAM PHARMACEUTICALS, INC. annual investing cash flow for 2024 was $-116.8M, a 65.26% increase from 2023.
What was ALNYLAM PHARMACEUTICALS, INC.'s investing cash flow in 2023?
ALNYLAM PHARMACEUTICALS, INC. annual investing cash flow for 2023 was $-336.4M, a 298.61% decline from 2022.
Investing Cash Flow History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGRN/A
FY2020
$-435.5M
→
FY2025
$436.3M
080910111213141516171819202122232425
5 years selected
Investing Cash Flow History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $436.3M | +473.4% | 10-K |
| FY2024 | $-116.8M | +65.3% | 10-K |
| FY2023 | $-336.4M | -298.6% | 10-K |
| FY2022 | $169.4M | +162.0% | 10-K |
| FY2021 | $-273.3M | +37.2% | 10-K |
| FY2020 | $-435.5M | -4.3% | 10-K |
| FY2019 | $-417.7M | -253.0% | 10-K |
| FY2018 | $272.9M | +194.0% | 10-K |
| FY2017 | $-290.4M | -303.6% | 10-K |
| FY2016 | $142.6M | +144.4% | 10-K |
| FY2015 | $-321.3M | +41.5% | 10-K |
| FY2014 | $-548.8M | -320.5% | 10-K |
| FY2013 | $-130.5M | -3968.0% | 10-K |
| FY2012 | $3.4M | -95.9% | 10-K |
| FY2011 | $82.0M | +359.5% | 10-K |
| FY2010 | $17.8M | +23.6% | 10-K |
| FY2009 | $14.4M | -19.5% | 10-K |
| FY2008 | $17.9M | - | 10-K |
Company: ALNYLAM PHARMACEUTICALS, INC.Ticker: ALNYSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →